Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

14/10 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
26/26/26	€0.5940	-1.00%
25/26/25	€0.6000	-1.15%
24/26/24	€0.6070	0.00%
21/26/21	€0.6070	-1.30%
20/26/20	€0.6150	+2.50%

Delayed Quote Deutsche Boerse AG

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Deutsche Boerse AG 11:31:30 26/08/2026 am IST			5-day change	1st Jan Change
0.5940 ^EUR	-1.00%		-1.00%	-

24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI

Market Cap	4.72Cr 5.49Cr 4.43Cr 4.04Cr 7.63Cr 524.01Cr 7.67Cr 52Cr 20Cr 264.36Cr 21Cr 20Cr 875.58Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.5Cr 6.41Cr 5.16Cr 4.72Cr 8.9Cr 611.26Cr 8.94Cr 61Cr 24Cr 308.38Cr 24Cr 24Cr 1.02TCr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	39.01%	Yield 2024 *	-	Yield 2025	-

24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
01/06	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
11/05	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

23/07	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
15/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
18/06	Theraclion Announces the Evolution of Its Board of Directors	BU
08/06	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

Theraclion Share Price Deutsche Boerse AG

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Price Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

23/07	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
15/07	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
09/07	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
19/06	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

1 day	-1.00%
1 week	-1.00%
Current month	+9.59%
1 month	+7.22%
3 months	+10.00%

1 week	0.59	0.62
1 month	0.54	0.63
Current year	0.44	0.93
1 year	0.44	0.93
3 years	0.44	0.93
5 years	0.44	0.93
10 years	0.44	0.93

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	-1.00%	-1.00%	-	-	5.41Cr
THERMO FISHER SCIENTIFIC, INC.	+0.89%	+3.29%	+29.73%	+17.01%	23TCr
DANAHER CORPORATION	-0.28%	+1.83%	+4.42%	-15.72%	15TCr
INTUITIVE SURGICAL, INC.	-0.38%	-6.86%	-21.90%	+24.49%	13TCr
BOSTON SCIENTIFIC CORPORATION	-3.39%	-7.38%	-54.72%	-5.10%	7.23TCr
SIEMENS HEALTHINEERS AG	-1.11%	-1.80%	-16.89%	-13.58%	5.16TCr
EDWARDS LIFESCIENCES CORPORATION	-0.10%	-1.63%	+11.70%	+19.18%	5.24TCr
AGILENT TECHNOLOGIES, INC.	+0.20%	-0.21%	+31.09%	+29.58%	4.37TCr
WATERS CORPORATION	-0.07%	-0.40%	+39.86%	+51.51%	4.07TCr
ILLUMINA, INC.	-0.07%	+9.68%	+127.73%	+42.23%	3.4TCr
Average	-0.53%	+1.58%	+16.78%	+16.62%	9TCr
Weighted average by Cap.	-0.23%	+0.73%	+9.64%	+11.78%

	2024	2025
Net sales	8L 10L 8L 7L 13.43L 9.23Cr 13.5L 92.22L 35.74L 4.65Cr 36.32L 35.53L 15Cr	7L 8L 6L 6L 10.55L 7.25Cr 10.6L 72.42L 28.07L 3.66Cr 28.52L 27.9L 12Cr
Net income	-57.57L -67.08L -54.04L -49.35L -93.14L -64Cr -93.59L -6.39Cr -2.48Cr -32Cr -2.52Cr -2.46Cr -106.9Cr	-56.9L -66.29L -53.41L -48.78L -92.06L -63Cr -92.5L -6.32Cr -2.45Cr -32Cr -2.49Cr -2.44Cr -105.65Cr
Net Debt	34.11L 39.74L 32.01L 29.24L 55.18L 38Cr 55.45L 3.79Cr 1.47Cr 19Cr 1.49Cr 1.46Cr 63Cr	78.52L 91.48L 73.7L 67.31L 1.27Cr 87Cr 1.28Cr 8.72Cr 3.38Cr 44Cr 3.43Cr 3.36Cr 145.8Cr